Dupixent 300 MG/2 ML pen 2ML
Ended Awarded
- Contract number
- SPE2DB25FX30X
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $3,419
Award facts
- Contract value 100% obligated
- $3,418.92 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,418.92 to AmerisourceBergen Drug Corp for Dupixent 300 mg/2 ml pen injectors on August 14, 2025, with an ultimate completion date of August 15, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 and extending through December 2026. The product will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania.
This delivery order supports the DLA Medical Supply Chain's pharmaceutical procurement operations, which serve military healthcare systems, the Defense Health Agency, U.S. Coast Guard, and other federal healthcare entities. As a major pharmaceutical distributor, AmerisourceBergen leverages its comprehensive IDC vehicle to fulfill critical medical supply needs across multiple therapeutic domains. Dupixent is a specialty biologic medication used primarily for moderate-to-severe eczema, asthma, and chronic rhinosinusitis treatment, reflecting the federal government's procurement of specialized pharmaceutical commodities to support military and veteran healthcare requirements.
Quick answers
Who was awarded contract SPE2DB25FX30X?
SPE2DB25FX30X was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 14, 2025.
How much is contract SPE2DB25FX30X worth?
The government has obligated $3,419 on SPE2DB25FX30X.
Is contract SPE2DB25FX30X an order under another contract?
Yes. SPE2DB25FX30X is a delivery order under SPE2DB20D2200, an indefinite delivery contract.
Was contract SPE2DB25FX30X competed?
The extent of competition for SPE2DB25FX30X was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award